Galectin Therapeutics (GALT) Dividends payables Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Jun 30, 2024 | -1.56% |
| Dec 31, 2023 | -1.56% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | -1.54% |
| Jun 30, 2022 | -1.54% |
| Dec 31, 2021 | 0.00% |
| Jun 30, 2021 | -1.52% |
| Dec 31, 2020 | -1.52% |
| Jun 30, 2020 | 0.00% |
| Dec 31, 2019 | -77.93% |
| Jun 30, 2019 | -1.49% |
| Dec 31, 2018 | 339.71% |
| Jun 30, 2018 | -1.47% |
| Dec 31, 2017 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Dec 31, 2016 | 1.49% |
| Jun 30, 2016 | 0.00% |
| Dec 31, 2015 | -1.47% |
| Jun 30, 2015 | -1.45% |
| Dec 31, 2014 | -6.85% |
| Jun 30, 2014 | -12.66% |
| Dec 31, 2013 | -8.75% |
| Jun 30, 2013 | -1.25% |
| Dec 31, 2012 | 0.00% |
| Jun 30, 2012 | -1.23% |
| Dec 31, 2011 | 66.67% |